<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Metanx is a product containing L-methylfolate, <z:chebi fb="0" ids="18405">pyridoxal 5'-phosphate</z:chebi>, and <z:chebi fb="0" ids="28115">methylcobalamin</z:chebi> for management of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Metanx ingredients counteract endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase uncoupling and <z:mp ids='MP_0003674'>oxidative stress</z:mp> in vascular endothelium and peripheral nerve </plain></SENT>
<SENT sid="2" pm="."><plain>This study evaluates Metanx on diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> in ZDF rats, a model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Metanx was administered to 15-week-old ZDF and ZDF lean rats at either 4.87 mg ��� kg(-1) ⋅ day(-1) (a body weight-based equivalent of human dose) or 24.35 mg ⋅ kg(-1) ⋅ day(-1) by oral gavage two times a day for 4 weeks </plain></SENT>
<SENT sid="4" pm="."><plain>Both doses alleviated hind limb digital sensory, but not sciatic motor, nerve conduction slowing and thermal and mechanical <z:mp ids='MP_0003043'>hypoalgesia</z:mp> in the absence of any reduction of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Low-dose Metanx increased intraepidermal nerve fiber density but did not prevent morphometric changes in distal tibial nerve myelinated fibers </plain></SENT>
<SENT sid="6" pm="."><plain>Metanx treatment counteracted endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase uncoupling, inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase upregulation, and <z:chebi fb="0" ids="17158">methylglyoxal</z:chebi>-derived advanced glycation end product, nitrotyrosine, and <z:chebi fb="95" ids="16301">nitrite</z:chebi>/nitrate accumulation in the peripheral nerve </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, Metanx, at a body weight-based equivalent of human dose, increased intraepidermal nerve fiber density and improved multiple parameters of peripheral nerve function in ZDF rats </plain></SENT>
<SENT sid="8" pm="."><plain>Clinical studies are needed to determine if Metanx finds use in management of diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> </plain></SENT>
</text></document>